AllianceBernstein L.P. 13D and 13G filings for Coherus BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:00 pm Sale | 2024-02-14 | 13G | Coherus BioSciences, Inc. CHRS | AllianceBernstein L.P. | 156,000 0.100% | -6,023,005 (-97.48%) | Filing |
| 2023-02-13 7:15 pm Purchase | 2023-02-14 | 13G | Coherus BioSciences, Inc. CHRS | AllianceBernstein L.P. | 6,179,005 8.000% | 510,477 (+9.01%) | Filing |
| 2022-02-14 2:45 pm Purchase | 2022-02-14 | 13G | Coherus BioSciences, Inc. CHRS | AllianceBernstein L.P. | 5,668,528 7.400% | 1,012,629 (+21.75%) | Filing |
| 2021-02-05 6:23 pm Purchase | 2021-02-15 | 13G | Coherus BioSciences, Inc. CHRS | AllianceBernstein L.P. | 4,655,899 6.500% | 4,655,899 (New Position) | Filing |